BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1245 related articles for article (PubMed ID: 24000138)

  • 1. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model.
    Tang FY; Pai MH; Chiang EP
    J Nutr Biochem; 2012 Oct; 23(10):1302-13. PubMed ID: 22221675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.
    Huang J; Che MI; Lin NY; Hung JS; Huang YT; Lin WC; Huang HC; Lee PH; Liang JT; Huang MC
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E62-71. PubMed ID: 23390052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
    Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
    Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
    Wang F; Ruan XJ; Zhang HY
    Tumori; 2015; 101(2):238-45. PubMed ID: 25908029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells.
    Suman S; Das TP; Sirimulla S; Alatassi H; Ankem MK; Damodaran C
    Oncotarget; 2016 Mar; 7(12):13854-64. PubMed ID: 26883103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress induces proliferation of colorectal cancer cells by inhibiting RUNX3 and activating the Akt signaling pathway.
    Kang KA; Kim KC; Bae SC; Hyun JW
    Int J Oncol; 2013 Nov; 43(5):1511-6. PubMed ID: 24042352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
    Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
    World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.
    Dai X; Ge J; Wang X; Qian X; Zhang C; Li X
    Oncol Rep; 2013 Jan; 29(1):155-60. PubMed ID: 23076549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
    Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
    Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
    Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
    Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.